March 4, 2026
TOPLINE: Patients with migraine had a higher risk of developing depression or anxiety than individuals without migraine, and this elevated risk persisted after accounting for shared […]
March 2, 2026
Healthy eating in midlife was associated with better cognitive performance and lower risk of subjective cognitive decline (SCD) in three large prospective studies of US health […]
March 2, 2026
Efgartigimod (Vyvgart, argenx) led to statistically significant improvements in symptoms of ocular myasthenia gravis (MG) in the phase 3 ADAPT OCULUS trial, according to topline results […]
March 2, 2026
The decades-old observation that smoking is linked to a lower risk for Parkinson’s disease (PD) has resurfaced in a large national cohort study — this time […]
March 2, 2026
A large study published in the Journal of Speech, Language, and Hearing Research systematically analyzes the genes that have so far been proposed to be involved […]
February 27, 2026
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use adopted a positive opinion for Onerji (levodopa/carbidopa, Tanabe Pharma) for the treatment of adults […]
February 27, 2026
The European Medicines Agency (EMA) has recommended refusal of marketing authorization for two new drugs, one for Rett syndrome and the other for schizophrenia. In each […]
February 27, 2026
The combination of placenta-derived stem cells (PMSCs) with standard in utero repair for severe spina bifida appears feasible and safe, with no cell-related adverse events observed […]
February 25, 2026
“A lot of people think anesthesia is an off switch, and then you turn it back on later,” said Boris Heifets, MD, PhD, Professor of Anesthesiology, […]